CKS1B as a potential target for prognostic assessment and intervention in pancreatic cancer and its role in abnormal proliferation and cellular phenotype through mediation of cell cycle signaling pathways

References

1. 1.↵
   1. Siegel RL,
   2. Miller KD,
   3. Fuchs HE,
   4. Jemal A

   . Cancer statistics, 2021. CA Cancer J Clin 2021; 71: 7-33.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Nedelcu A,
   2. Mocan T,
   3. Grapa C,
   4. Mocan L

   . Recent advances in nanoparticle-mediated diagnosis and the treatment of pancreatic cancer. Int J Mol Sci 2021; 22: 8060.

   OpenUrl
3. 3.↵
   1. Grey W,
   2. Rio-Machin A,
   3. Casado P,
   4. Grönroos E,
   5. Ali S,
   6. Miettinen JJ, et al.

   CKS1 inhibition depletes leukemic stem cells and protects healthy hematopoietic stem cells in acute myeloid leukemia. Sci Transl Med 2022; 14: eabn3248.

   OpenUrl
4. 4.↵
   1. Zhang Y,
   2. Chen Y,
   3. You F,
   4. Li W,
   5. Lang Z,
   6. Zou Z

   . Prognostic and clinicopathological significance of CKS1 in cancer: evidence from a meta-analysis. J Cell Physiol 2019; 234: 13423-13430.

   OpenUrl
5. 5.↵
   1. Kandil NS,
   2. Kandil LS,
   3. Mohamed R,
   4. Selima M,
   5. El Nemr M,
   6. Barakat AR, et al.

   The role of miRNA-182 and FOXO3 expression in breast cancer. Asian Pac J Cancer Prev 2022; 23: 3361-3370.

   OpenUrl
6. 6.↵
   1. Oh ET,
   2. Kim HG,
   3. Kim CH,
   4. Lee J,
   5. Kim C,
   6. Lee JS, et al.

   NQO1 regulates cell cycle progression at the G2/M phase. Theranostics 2023; 13: 873-895.

   OpenUrl
7. 7.↵
   1. Pai JT,
   2. Hsu MW,
   3. Leu YL,
   4. Chang KT,
   5. Weng MS

   . Induction of G2/M cell cycle arrest via p38/p21^Waf1/Cip1-dependent signaling pathway activation by bavachinin in non-small-cell lung cancer cells. Molecules 2021; 26: 5161.

   OpenUrl
8. 8.↵
   1. Barnaba N,
   2. LaRocque JR

   . Targeting cell cycle regulation via the G2-M checkpoint for synthetic lethality in melanoma. Cell Cycle 2021; 20: 1041-1051.

   OpenUrl
9. 9.↵
   1. Shi W,
   2. Huang Q,
   3. Xie J,
   4. Wang H,
   5. Yu X,
   6. Zhou Y

   . CKS1B as drug resistance-inducing gene-A potential target to improve cancer therapy. Front Oncol 2020; 10: 582451.

   OpenUrl
10. 10.↵
    1. Kang YS,
    2. Jeong EJ,
    3. Seok HJ,
    4. Kim SK,
    5. Hwang JS,
    6. Choi ML, et al.

    CKS1 regulates human hepatocellular carcinoma cell progression through osteopontin expression. Biochem Biophys Res Commun 2019; 508: 275-281.

    OpenUrl
11. 11.
    1. Wang X,
    2. Tao G,
    3. Huang D,
    4. Liang S,
    5. Zheng D

    . Circular RNA NOX4 promotes the development of colorectal cancer via the microRNA‑485‑5p/CKS1B axis. Oncol Rep 2020; 44: 2009-2020.

    OpenUrl
12. 12.↵
    1. Liu Y,
    2. Wang W,
    3. Li Y,
    4. Sun F,
    5. Lin J,
    6. Li L

    . CKS1BP7, a pseudogene of CKS1B, is co-amplified with IGF1R in breast cancers. Pathol Oncol Res 2018; 24: 223-229.

    OpenUrl
13. 13.↵
    1. Wang K,
    2. Zhang M,
    3. Wang J,
    4. Sun P,
    5. Luo J,
    6. Jin H, et al.

    A systematic analysis identifies key regulators involved in cell proliferation and potential drugs for the treatment of human lung adenocarcinoma. Front Oncol 2021; 11: 737152.

    OpenUrl
14. 14.↵
    1. Xie B,
    2. Wang S,
    3. Jiang N,
    4. Li JJ

    . Cyclin B1/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance. Cancer Lett 2019; 443: 56-66.

    OpenUrl
15. 15.↵
    1. Wang XM,
    2. Li QY,
    3. Ren LL,
    4. Liu YM,
    5. Wang TS,
    6. Mu TC, et al.

    Effects of MCRS1 on proliferation, migration, invasion, and epithelial mesenchymal transition of gastric cancer cells by interacting with PKMYT1 protein kinase. Cell Signal 2019; 59: 171-181.

    OpenUrl
16. 16.↵
    1. Jeong D,
    2. Kim H,
    3. Kim D,
    4. Ban S,
    5. Oh S,
    6. Ji S, et al.

    Protein kinase, membrane‑associated tyrosine/threonine 1 is associated with the progression of colorectal cancer. Oncol Rep 2018; 39: 2829-2836.

    OpenUrl
17. 17.↵
    1. Xuan ZH,
    2. Wang HP,
    3. Zhang XN,
    4. Chen ZX,
    5. Zhang HY,
    6. Gu MM

    . PKMYT1 aggravates the progression of ovarian cancer by targeting SIRT3. Eur Rev Med Pharmacol Sci 2020; 24: 5259-5266.

    OpenUrl
18. 18.
    1. Zhang QY,
    2. Chen XQ,
    3. Liu XC,
    4. Wu DM

    . PKMYT1 promotes gastric cancer cell proliferation and apoptosis resistance. Onco Targets Ther 2020; 13: 7747-7757.

    OpenUrlCrossRef
19. 19.↵
    1. Fang Y,
    2. Zhang X,
    3. Guo Y,
    4. Dong Y,
    5. Liu W,
    6. Hu X, et al.

    PKMYT1: a potential target for CCNE1 amplificated colorectal tumors. Cell Biochem Biophys 2023; 81: 569-576.

    OpenUrl
20. 20.↵
    1. Long HP,
    2. Liu JQ,
    3. Yu YY,
    4. Qiao Q,
    5. Li G

    . PKMYT1 as a potential target to improve the radiosensitivity of lung adenocarcinoma. Front Genet 2020; 11: 376.

    OpenUrl
21. 21.↵
    1. Wang J,
    2. Wang L,
    3. Chen S,
    4. Peng H,
    5. Xiao L,
    6. E Du, et al.

    PKMYT1 is associated with prostate cancer malignancy and may serve as a therapeutic target. Gene 2020; 744: 144608.

    OpenUrlCrossRef
22. 22.↵
    1. Hwang JS,
    2. Jeong EJ,
    3. Choi J,
    4. Lee YJ,
    5. Jung E,
    6. Kim SK, et al.

    MicroRNA-1258 inhibits the proliferation and migration of human colorectal cancer cells through suppressing CKS1B expression. Genes (Basel) 2019; 10: 912.

    OpenUrl
23. 23.↵
    1. Li P,
    2. Wang H,
    3. Tang Y,
    4. Sun S,
    5. Ma Y,
    6. Xu Y, et al.

    Knockdown of LINC00657 inhibits the viability, migration and invasion of pancreatic cancer cells by regulating the miR-520h/CKS1B axis. Exp Ther Med 2021; 22: 1142.

    OpenUrl
24. 24.↵
    1. Oboshi W,
    2. Hayashi K,
    3. Takeuchi H,
    4. Ikeda K,
    5. Yamaguchi Y,
    6. Kimura A, et al.

    MicroRNA-150 suppresses p27^Kip1 expression and promotes cell proliferation in HeLa human cervical cancer cells. Oncol Lett 2020; 20: 210.

    OpenUrl
25. 25.↵
    1. Yao B,
    2. Zhang Q,
    3. Yang Z,
    4. An F,
    5. Nie H,
    6. Wang H, et al.

    CircEZH2/miR-133b/IGF2BP2 aggravates colorectal cancer progression via enhancing the stability of m6A-modified CREB1 mRNA. Mol Cancer 2022; 21: 140.

    OpenUrl
26. 26.↵
    1. Doghish AS,
    2. Abulsoud AI,
    3. Elshaer SS,
    4. Abdelmaksoud NM,
    5. Zaki MB,
    6. El-Mahdy HA, et al.

    miRNAs as cornerstones in chronic lymphocytic leukemia pathogenesis and therapeutic resistance- an emphasis on the interaction of signaling pathways. Pathol Res Pract 2023; 243: 154363.

    OpenUrl